Literature DB >> 19012347

The spectrum of syndromes and manifestations in individuals screened for suspected Marfan syndrome.

Meike Rybczynski1, Alexander M J Bernhardt, Uwe Rehder, Bettina Fuisting, Ludwig Meiss, Ursula Voss, Christian Habermann, Christian Detter, Peter N Robinson, Mine Arslan-Kirchner, Jörg Schmidtke, Thomas S Mir, Jürgen Berger, Thomas Meinertz, Yskert von Kodolitsch.   

Abstract

The diagnosis of Marfan syndrome (MFS) is based on evaluating a large number of clinical criteria. We have observed that many persons presenting in specialized centers for "Marfan-like" features do not have MFS, but exhibit a large spectrum of other syndromes. The spectrum of these syndromes and the distribution of "Marfan-like" features remain to be characterized. Thus, we prospectively evaluated 279 consecutive patients with suspected MFS (144 men and 135 women at a mean age of 34+/-13 years) for presence of 27 clinical criteria considered characteristic of MFS. The most frequent reasons to refer individuals for suspected MFS were skeletal features (31%), a family history of MFS, or aortic complications (29%), aortic dissection or aneurysm (19%), and eye manifestations (9%). Using established criteria, we confirmed MFS in 138 individuals (group 1) and diagnosed other connective tissue diseases, both with vascular involvement in 30 (group 2) and without vascular involvement in 39 (group 3), and excluded any distinct disease in 72 individuals (group 4). Clinical manifestations of MFS were present in all four patient groups and there was no single clinical criterion that exhibited positive and negative likelihood ratios that were per se sufficient to confirm or rule out MFS. We conclude that "Marfan-like" features are not exclusively indicative of MFS but also of numerous, alternative inherited diseases with many of them carrying a hitherto poorly defined cardiovascular risk. These alternative diseases require future study to characterize their responses to therapy and long-term prognosis. Copyright (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19012347     DOI: 10.1002/ajmg.a.32595

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  25 in total

1.  Heart rate turbulence and deceleration capacity for risk prediction of serious arrhythmic events in Marfan syndrome.

Authors:  Benjamin N Schaeffer; Meike Rybczynski; Sara Sheikhzadeh; Ruken Ö Akbulak; Julia Moser; Mario Jularic; Doreen Schreiber; Anne Daubmann; Stephan Willems; Yskert von Kodolitsch; Boris A Hoffmann
Journal:  Clin Res Cardiol       Date:  2015-06-02       Impact factor: 5.460

2.  Corneal Deformation Response and Ocular Geometry: A Noninvasive Diagnostic Strategy in Marfan Syndrome.

Authors:  Lauren C Beene; Elias I Traboulsi; Ibrahim Seven; Matthew R Ford; Abhijit Sinha Roy; Robert S Butler; William J Dupps
Journal:  Am J Ophthalmol       Date:  2015-10-24       Impact factor: 5.258

3.  Total serum transforming growth factor-β1 is elevated in the entire spectrum of genetic aortic syndromes.

Authors:  Mathias Hillebrand; Nathalie Millot; Sara Sheikhzadeh; Meike Rybczynski; Sabine Gerth; Tilo Kölbel; Britta Keyser; Kerstin Kutsche; Peter N Robinson; Jürgen Berger; Thomas S Mir; Tanja Zeller; Stefan Blankenberg; Yskert von Kodolitsch; Britta Goldmann
Journal:  Clin Cardiol       Date:  2014-08-11       Impact factor: 2.882

4.  The diagnostic value of the facial features of Marfan syndrome.

Authors:  Beverlie L Ting; Deepti Mathur; Bart L Loeys; Harry C Dietz; Paul D Sponseller
Journal:  J Child Orthop       Date:  2010-10-31       Impact factor: 1.548

5.  Decreased frequency of FBN1 missense variants in Ghent criteria-positive Marfan syndrome and characterization of novel FBN1 variants.

Authors:  Linnea M Baudhuin; Katrina E Kotzer; Susan A Lagerstedt
Journal:  J Hum Genet       Date:  2015-02-05       Impact factor: 3.172

6.  Rare variants in FBN1 and FBN2 are associated with severe adolescent idiopathic scoliosis.

Authors:  Jillian G Buchan; David M Alvarado; Gabe E Haller; Carlos Cruchaga; Matthew B Harms; Tianxiao Zhang; Marcia C Willing; Dorothy K Grange; Alan C Braverman; Nancy H Miller; Jose A Morcuende; Nelson Leung-Sang Tang; Tsz-Ping Lam; Bobby Kin-Wah Ng; Jack Chun-Yiu Cheng; Matthew B Dobbs; Christina A Gurnett
Journal:  Hum Mol Genet       Date:  2014-05-15       Impact factor: 6.150

7.  Impact of age and gender on cardiac pathology in children and adolescents with Marfan syndrome.

Authors:  Goetz C Mueller; Veronika Stark; Kristoffer Steiner; Yskert von Kodolitsch; Meike Rybczynski; Jochen Weil; Thomas S Mir
Journal:  Pediatr Cardiol       Date:  2012-11-25       Impact factor: 1.655

Review 8.  Perspectives on the revised Ghent criteria for the diagnosis of Marfan syndrome.

Authors:  Yskert von Kodolitsch; Julie De Backer; Helke Schüler; Peter Bannas; Cyrus Behzadi; Alexander M Bernhardt; Mathias Hillebrand; Bettina Fuisting; Sara Sheikhzadeh; Meike Rybczynski; Tilo Kölbel; Klaus Püschel; Stefan Blankenberg; Peter N Robinson
Journal:  Appl Clin Genet       Date:  2015-06-16

9.  Observational cohort study of ventricular arrhythmia in adults with Marfan syndrome caused by FBN1 mutations.

Authors:  Ali Aydin; Baran A Adsay; Sara Sheikhzadeh; Britta Keyser; Meike Rybczynski; Claudia Sondermann; Christian Detter; Daniel Steven; Peter N Robinson; Jürgen Berger; Jörg Schmidtke; Stefan Blankenberg; Stephan Willems; Yskert von Kodolitsch; Boris A Hoffmann
Journal:  PLoS One       Date:  2013-12-13       Impact factor: 3.240

Review 10.  Pectus excavatum and heritable disorders of the connective tissue.

Authors:  Francesca Tocchioni; Marco Ghionzoli; Antonio Messineo; Paolo Romagnoli
Journal:  Pediatr Rep       Date:  2013-09-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.